GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Dr. Agarwals Health Care Ltd

Dr. Agarwals Health Care Q2 FY27 Consolidated Revenue Up 31.4% YoY to ₹655 Cr

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 05 Nov 2026, 06:10 PM IST  ·  BSE ID: 62cf1c57-34c7-4336-98f1-353d6c3fddfa
View Original BSE Filing (PDF)
💡
In Simple Terms
The eye care company reported higher revenue and profits for the September 2026 quarter and half-year, expanding its network of facilities.
🤖 AI Summary
  • Consolidated Revenue from Operations for Q2 FY27 was ₹655 Cr, representing a 31.4% year-on-year growth.
  • Consolidated Profit After Tax (PAT) for Q2 FY27 reached ₹57 Cr, marking a 55.8% year-on-year increase.
  • For H1 FY27, consolidated revenue from operations stood at ₹1,269 Cr, growing 28.7% year-on-year.
  • H1 FY27 consolidated PAT was ₹112 Cr, up 50.1% year-on-year, and EBITDA was ₹362 Cr, up 27.0% YoY.
  • The company's operational footprint includes 324 eye care facilities as of September 30, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Q2 FY27 Consolidated Revenue from Operations
₹655 Cr.
31.4% YoY Growth
Q2 FY27 Consolidated Profit After Tax
₹57 Cr.
55.8% YoY Growth
H1 FY27 Consolidated Revenue from Operations
₹1,269 Cr.
28.7% YoY Growth
H1 FY27 Consolidated Profit After Tax
₹112 Cr.
50.1% YoY Growth
Number of Eye Care Facilities (as of Sep 30, 2026)
324
🏢 How This Affects the Company
📈
Business Impact
The company's market position is strengthened by a 31.4% YoY revenue growth in Q2 FY27 and expansion to 324 eye care facilities. Geographic diversification is noted with 14 states and 9 countries served.
💰
Financial Impact
Strong financial performance with Q2 FY27 consolidated PAT up 55.8% YoY to ₹57 Cr and H1 FY27 PAT up 50.1% YoY to ₹112 Cr indicates improved profitability.
⚙️
Operational Impact
Operational capacity increased with 39 facility additions in H1 FY27, and 186K+ surgeries performed. The company also added a World’s First Pinhole Pupilloplasty (PPP) Centre.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results presentation.
👤
Who Is Affected
All shareholders are indirectly affected by the company's financial performance and operational expansion, which reflect on the underlying business value.
🔍
Management Signal
The financial presentation signals management's focus on expanding its operational footprint and achieving growth in revenue and profitability.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — check for sustained revenue and profit growth.
Updates on facility expansion plans and new additions in upcoming quarters.
Analyst/Earnings conference call details for further business insights.
LOW RISK The filing primarily reports positive financial results and operational growth with no explicit new risks.
💡 Investor Takeaway
Dr. Agarwals Health Care reported Q2 FY27 consolidated revenue from operations at ₹655 Cr, a 31.4% YoY increase, and Profit After Tax at ₹57 Cr, up 55.8% YoY. H1 FY27 consolidated revenue reached ₹1,269 Cr, growing 28.7% YoY, with PAT at ₹112 Cr, up 50.1% YoY. The company operates 324 eye care facilities as of September 30, 2026.
⚖️ Strengths & Concerns

✅ Positives

  • Q2 FY27 Consolidated Revenue from Operations increased by 31.4% YoY to ₹655 Cr, indicating strong top-line growth.
  • Q2 FY27 Consolidated Profit After Tax grew by 55.8% YoY to ₹57 Cr, demonstrating enhanced profitability.
📅 Company Track Record
Dr. Agarwals Health Care has consistently reported strong growth in recent quarters. Q1 FY27 saw consolidated revenue up 26.0% YoY to ₹614 Crores and PAT up 44.6% YoY to ₹55 Crores, indicating a sustained growth trend leading into the current period.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Dr. Agarwals Health Care's consolidated revenue in Q2 FY27?
Dr. Agarwals Health Care's consolidated revenue from operations for Q2 FY27 was ₹655 Cr, representing a 31.4% year-on-year growth.
What was Dr. Agarwals Health Care's consolidated Profit After Tax (PAT) for Q2 FY27?
The consolidated Profit After Tax (PAT) for Dr. Agarwals Health Care in Q2 FY27 was ₹57 Cr, an increase of 55.8% year-on-year.
How many eye care facilities does Dr. Agarwals Health Care operate as of September 30, 2026?
As of September 30, 2026, Dr. Agarwals Health Care operates a total of 324 eye care facilities.
What were the H1 FY27 consolidated financial results for Dr. Agarwals Health Care?
For H1 FY27, Dr. Agarwals Health Care reported consolidated revenue from operations of ₹1,269 Cr (28.7% YoY growth) and Profit After Tax of ₹112 Cr (50.1% YoY growth).

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.